NCT02772809

Brief Summary

Stroke survivors with hemiplegia will be evaluated by rehabilitation professionals and asked to perform a battery of assessments to test the viability and usability of a force-feedback robot that adapts to each individual subject's performance. Subsequently, they will be asked to complete post-assessment questionnaires that provide feedback to the researchers on their observations and thoughts about the therapy devices.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 16, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2017

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

September 4, 2020

Completed
Last Updated

September 4, 2020

Status Verified

September 1, 2020

Enrollment Period

3.3 years

First QC Date

March 29, 2016

Results QC Date

March 23, 2020

Last Update Submit

September 3, 2020

Conditions

Keywords

strokehemiplegiarehabilitationroboticsneuroplasticity

Outcome Measures

Primary Outcomes (3)

  • Fugl Meyer

    The primary outcomes are motor control for the upper limb: Subjects completed tasks on scale; Motor scale maximum is 66. minimum is 0. Lower is more impaired. Higher is less impaired.

    At 0 weeks

  • Box and Blocks

    Measures ADL Function. Completed reach and grasp activities. Reached for 1 inch cube and placed with impaired arm. More blocks indicate higher function. Less blocks lower function

    At Session 0. Pre-intervention

  • Tracking Accuracy

    Tracking accuracy is measured using the normalized root mean square, which is a measure for error in tracking performance with respect to a desired goal. Root mean squared divided by the maximum error if person does not move. The higher the decimal the higher the error made. Lower is better performance.

    At Session 0

Secondary Outcomes (3)

  • Grip Strength

    pre-intervention

  • Montreal Cognitive Assessment (MOCA)

    pre-intervention

  • Becks Depression Scale

    Pre-intervention

Study Arms (1)

Stroke survivors with low and moderate motor deficits

OTHER

Subjects with low and moderate motor deficits will 1) complete exercises with 2 commercial (joystick and wheel) and the Theradrive haptic robot after pre assessment 2) then experience 12 therapy sessions on the Theradrive haptic robot with Adaptive Feedback. 3) Assessments pre and post therapy.

Device: Haptic Robot Therapy with Games

Interventions

Commercial Joystick and Wheels Plus the Haptic TheraDrive Robot will be used. Haptic Theradrive is a low-cost robotic system for post-stroke upper extremity rehabilitation. The system uses off-the-shelf computer gaming wheels with force feedback to help reduce motor impairment and improve function in the arms of stroke survivors.

Stroke survivors with low and moderate motor deficits

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke survivors at least 18 years of age with hemiplegia.
  • The subject's stroke must have occurred at least 3 months prior to enrollment in the study.
  • Low and Moderate functioning stroke survivors as measured by Fugl- Meyer
  • Not depressed
  • No more than Mild Cognitive Deficit
  • Participants must be able to sit upright for 4 hours at a time in Part A of the study; and 2 hours at a time, 3 days a week, for Part B of the study.
  • The subject's stroke must have occurred at least 3 months prior to enrollment in the study.

You may not qualify if:

  • Greater than mild cognitive deficits
  • Greater than mild depression. A member of the research team will administer Beck's Depression Inventory (BDI) to each study participant over the phone. If the participant is found to have greater than mild depression, as measured by the BDI, they will not qualify for the study.
  • Receiving rehabilitation on the upper limb.
  • Received Botox injections within the past 3 months.
  • Suffering from contractures (chronic loss of joint motion) or debilitating spasticity in the upper extremity.
  • Experiencing greater than mild pain, and/or the PI determines that the participant should no longer continue working with the novel therapy devices, the study will be stopped.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Penn Medicine Rittenhouse

Philadelphia, Pennsylvania, 19146, United States

Location

Related Publications (3)

  • Ruparel R, Johnson MJ, Strachota E, McGuire J, Tchekanov G. Evaluation of the TheraDrive system for robot/computer assisted motivating rehabilitation after stroke. Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:811-4. doi: 10.1109/IEMBS.2009.5332386.

    PMID: 19963475BACKGROUND
  • Johnson MJ, Ramachandran B, Paranjape RP, Kosasih JB. Feasibility study of TheraDrive: a low-cost game-based environment for the delivery of upper arm stroke therapy. Conf Proc IEEE Eng Med Biol Soc. 2006;2006:695-8. doi: 10.1109/IEMBS.2006.259971.

    PMID: 17946851BACKGROUND
  • Theriault A, Nagurka M, Johnson MJ. Design and development of an affordable haptic robot with force-feedback and compliant actuation to improve therapy for patients with severe hemiparesis. IEEE Trans Haptics. 2014 Apr-Jun;7(2):161-74. doi: 10.1109/TOH.2013.51.

    PMID: 24968380BACKGROUND

Related Links

MeSH Terms

Conditions

StrokeHemiplegia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Michelle J Johnson
Organization
University of Pennsylvania

Study Officials

  • Michelle J Johnson, PhD

    PENN MEDICINE RITTENHOUSE

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2016

First Posted

May 16, 2016

Study Start

March 1, 2014

Primary Completion

July 1, 2017

Study Completion

July 1, 2017

Last Updated

September 4, 2020

Results First Posted

September 4, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations